Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Clinical Utility of DCISionRT® on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery.
Shah C, Bremer T, Cox C, Whitworth P, Patel R, Patel A, Brown E, Gold L, Rock D, Riley L, Kesslering C, Brown S, Gabordi R, Pellicane J, Rabinovich R, Khan S, Templeton S, Majithia L, Willey SC, Wärnberg F, Gerber NK, Shivers S, Vicini FA. Shah C, et al. Among authors: bremer t. Ann Surg Oncol. 2021 Oct;28(11):5974-5984. doi: 10.1245/s10434-021-09903-1. Epub 2021 Apr 5. Ann Surg Oncol. 2021. PMID: 33821346 Free PMC article.
Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy.
Weinmann S, Leo MC, Francisco M, Jenkins CL, Barry T, Leesman G, Linke SP, Whitworth PW, Patel R, Pellicane J, Wärnberg F, Bremer T. Weinmann S, et al. Among authors: bremer t. Clin Cancer Res. 2020 Aug 1;26(15):4054-4063. doi: 10.1158/1078-0432.CCR-19-1152. Epub 2020 Apr 27. Clin Cancer Res. 2020. PMID: 32341032
Correction to: The Clinical Utility of DCISionRT® on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery.
Shah C, Bremer T, Cox C, Whitworth P, Patel R, Patel A, Brown E, Gold L, Rock D, Riley L, Kesslering C, Brown S, Gabordi R, Pellicane J, Rabinovich R, Khan S, Templeton S, Majithia L, Willey SC, Wärnberg F, Gerber NK, Shivers S, Vicini FA. Shah C, et al. Among authors: bremer t. Ann Surg Oncol. 2021 Dec;28(Suppl 3):878. doi: 10.1245/s10434-021-10138-3. Ann Surg Oncol. 2021. PMID: 33997922 Free PMC article. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 34700539
Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS).
Wärnberg F, Karlsson P, Holmberg E, Sandelin K, Whitworth PW, Savala J, Barry T, Leesman G, Linke SP, Shivers SC, Vicini F, Shah C, Weinmann S, Mann GB, Bremer T. Wärnberg F, et al. Among authors: bremer t. Cancers (Basel). 2021 Dec 3;13(23):6103. doi: 10.3390/cancers13236103. Cancers (Basel). 2021. PMID: 34885211 Free PMC article.
A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy.
Vicini FA, Mann GB, Shah C, Weinmann S, Leo MC, Whitworth P, Rabinovitch R, Torres MA, Margenthaler JA, Dabbs D, Savala J, Shivers SC, Mittal K, Wärnberg F, Bremer T. Vicini FA, et al. Among authors: bremer t. Int J Radiat Oncol Biol Phys. 2023 Jan 1;115(1):93-102. doi: 10.1016/j.ijrobp.2022.06.072. Epub 2022 Sep 15. Int J Radiat Oncol Biol Phys. 2023. PMID: 36115740 Free article.
Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial.
Schiza A, Thurfjell V, Stenmark Tullberg A, Olofsson H, Lindberg A, Holmberg E, Bremer T, Micke P, Karlsson P, Wärnberg F, Strell C. Schiza A, et al. Among authors: bremer t. Eur J Cancer. 2022 Jun;168:128-137. doi: 10.1016/j.ejca.2022.01.016. Epub 2022 Feb 27. Eur J Cancer. 2022. PMID: 35236568 Free article. Clinical Trial.
47 results